Welcome to LookChem.com Sign In|Join Free

CAS

  • or
"4,4-Dihydroxy-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester hydrate" is a hydrate form of the tert-butyl ester of 4,4-dihydroxy-4,5,6,7-tetrahydro-indazole-1-carboxylic acid, a derivative of indazole. It is a compound used in the pharmaceutical industry as an intermediate in the synthesis of various drugs.
Used in Pharmaceutical Industry:
"4,4-Dihydroxy-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester hydrate" is used as a building block in the preparation of bioactive molecules for drug discovery and development. Its unique structure and properties make it a valuable tool for medicinal chemists and researchers in the field of pharmaceuticals.

955406-75-4

Post Buying Request

955406-75-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • tert-Butyl 4-oxo-4,5,6,7-tetrahydro-1H-indazole-1-carboxylate hydrate

    Cas No: 955406-75-4

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier

955406-75-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 955406-75-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,5,4,0 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 955406-75:
(8*9)+(7*5)+(6*5)+(5*4)+(4*0)+(3*6)+(2*7)+(1*5)=194
194 % 10 = 4
So 955406-75-4 is a valid CAS Registry Number.

955406-75-4Relevant articles and documents

MODULATORS OF LIPID STORAGE

-

Paragraph 0185-0187, (2013/06/06)

Disclosed are compounds of formulas I, II, and III: Formulas I, II, and III wherein R1-R19 and n are as described herein, or pharmaceutically acceptable salts thereof, or an enantiomer thereof or a conjugate thereof wherein the conju

CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1

-

, (2009/05/29)

The present invention discloses novel compounds of Formula (I): having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compound

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 955406-75-4